Evidence map›Paper›PMID 39158629›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2025

Assessing Sarcoma Awareness Among the General Population in Minnesota: A Cross-Sectional Survey Study from the Minnesota State Fair in 2015 and 2022.

Nea Fride, Kristine M Nachbor, Alexander T Nelson, Kirsten Snook, Rami M Shaker, Sophia Mavrommatis, Christopher D Seaver, Lachelle Semanko, Manpreet Bedi, Elsa Keeler and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nea FrideDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Kristine M NachborDepartment of Ophthalmology and Visual Science, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-1320-7719
Alexander T NelsonDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-1611-4577
Kirsten SnookDepartment of Pediatrics, University of Colorado, Aurora, CO, USA.
Rami M ShakerDepartment of Medicine, UnityPoint Health, University of Iowa, Des Moines, IA, USA.ORCID 0000-0002-5394-1563
Sophia MavrommatisDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-3027-3475
Christopher D SeaverDepartment of Orthopedic Surgery, Albany Medical College, Albany, NY, USA.ORCID 0009-0007-9479-7071
Lachelle SemankoRein in Sarcoma, Fridley, MN, USA.
Manpreet BediDepartment of Radiation Oncology, Cancer Center - Froedtert Hospital, Milwaukee, WI, USA.ORCID 0000-0002-3269-5711
Elsa KeelerRein in Sarcoma, Fridley, MN, USA.
Kathryn E DusenberyRein in Sarcoma, Fridley, MN, USA.
Amber A RetzlaffDepartment of Radiation Oncology, Abbott Northwestern Hospital, 800 E 28th Street, Minneapolis, MN, 55407, USA. retz0021@umn.edu.ORCID 0000-0002-6081-3869

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcomas are commonly misdiagnosed, and treatment delays negatively impact patient outcomes. The purpose of this study is to explore patient threshold for and timeline to medical evaluation, to identify providers most likely to be contacted first, and to assess general sarcoma knowledge in Minnesota's general population. Voluntary participants were recruited at the 2015 and 2022 Minnesota State Fair to complete a three-part survey. Part 1 assessed evaluation timeline and provider choice, part 2 evaluated sarcoma knowledge via a ten-question survey, and part 3 documented demographics. Responses were electronically recorded, and results were tabulated. Overall, 2124 participants completed some or all of the survey. Part 1: Participants indicated they would seek more urgent treatment for a painful mass compared to a non-painful mass (p < 0.001). The majority (77%) of participants indicated a family medicine physician would be their first contact for painful and non-painful masses. Part 2: There was no difference in overall score (percent correct) when comparing results from 2015 (mean = 40%) to 2022 (mean = 42%) (p = 0.183). Overall, 16% (349/2117) of participants had no correct responses. Individuals who self-identified as Hispanic or Latino ethnicity and a non-White race performed worse (p < 0.001). In general, scores improved with increased education and those with a graduate or professional degree had an estimated 2.515-point increase in score compared to participants with some high school education or high school diploma/general education diploma (p < 0.001). Participants with a healthcare background scored better (p < 0.001). Pain is a driving factor for patient-initiated evaluation, and primary care providers are the most likely first contact for patients. General sarcoma awareness remains low, even among those with advanced degrees and healthcare experience. Ongoing educational efforts are warranted for both the general public and healthcare communities in Minnesota.

Indexed as

Health Knowledge, Attitudes, PracticeSarcomaAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedMinnesotaSurveys and QuestionnairesYoung AdultBone sarcomaSarcomaSarcoma awarenessSoft tissue sarcoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.